These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 18174680

  • 1. The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease.
    Baumgart DC, Buning C, Geerdts L, Schmidt HH, Genschel J, Fiedler T, Gentz E, Molnar T, Nagy F, Lonovics J, Lochs H, Wiedenmann B, Nickel R, Witt H, Dignass A.
    Digestion; 2007; 76(3-4):196-202. PubMed ID: 18174680
    [Abstract] [Full Text] [Related]

  • 2. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort.
    Petermann I, Huebner C, Browning BL, Gearry RB, Barclay ML, Kennedy M, Roberts R, Shelling AN, Philpott M, Han DY, Ferguson LR.
    Hum Immunol; 2009 Jun; 70(6):440-6. PubMed ID: 19275920
    [Abstract] [Full Text] [Related]

  • 3. Relevance of endotoxin receptor CD14 and TLR4 gene variants in chronic liver disease.
    Von Hahn T, Halangk J, Witt H, Neumann K, Müller T, Puhl G, Neuhaus P, Nickel R, Beuers U, Wiedenmann B, Berg T.
    Scand J Gastroenterol; 2008 Jun; 43(5):584-92. PubMed ID: 18415752
    [Abstract] [Full Text] [Related]

  • 4. DLG5 variants in inflammatory bowel disease.
    Büning C, Geerdts L, Fiedler T, Gentz E, Pitre G, Reuter W, Luck W, Buhner S, Molnar T, Nagy F, Lonovics J, Dignass A, Landt O, Nickel R, Genschel J, Lochs H, Schmidt HH, Witt H.
    Am J Gastroenterol; 2006 Apr; 101(4):786-92. PubMed ID: 16494592
    [Abstract] [Full Text] [Related]

  • 5. Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort.
    Papp M, Lakatos PL, Harsfalvi J, Farkas G, Palatka K, Udvardy M, Molnar T, Farkas K, Nagy F, Veres G, Lakatos L, Kovacs A, Dinya T, Kocsis AK, Papp J, Hungarian IBD Study Group, Altorjay I.
    Hum Immunol; 2010 Apr; 71(4):407-13. PubMed ID: 20079790
    [Abstract] [Full Text] [Related]

  • 6. NOD2/CARD15 and Toll-like 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease.
    Figueroa C, Peralta A, Herrera L, Castro P, Gutiérrez A, Valenzuela J, Aguillón JC, Quera R, Hermoso MA.
    Eur Cytokine Netw; 2006 Jun; 17(2):125-30. PubMed ID: 16840031
    [Abstract] [Full Text] [Related]

  • 7. TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease.
    Fidder HH, Heijmans R, Chowers Y, Bar-Meir S, Avidan B, Pena AS, Crusius JB.
    Int J Immunogenet; 2006 Apr; 33(2):81-5. PubMed ID: 16611251
    [Abstract] [Full Text] [Related]

  • 8. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
    Glas J, Konrad A, Schmechel S, Dambacher J, Seiderer J, Schroff F, Wetzke M, Roeske D, Török HP, Tonenchi L, Pfennig S, Haller D, Griga T, Klein W, Epplen JT, Folwaczny C, Lohse P, Göke B, Ochsenkühn T, Mussack T, Folwaczny M, Müller-Myhsok B, Brand S.
    Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
    [Abstract] [Full Text] [Related]

  • 9. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J, Subrt I, Dìdek P, Siala K, Schwarz J, Machalová V, Varvarovská J, Pazdiora P, Pozler O, Stozický F.
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [Abstract] [Full Text] [Related]

  • 10. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M, Altorjay I, Dotan N, Palatka K, Foldi I, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Norman GL, Szamosi T, Papp J, Hungarian IBD Study Group, Lakatos PL.
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [Abstract] [Full Text] [Related]

  • 11. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ, Nickerson P, Bernstein CN.
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [Abstract] [Full Text] [Related]

  • 12. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP, Glas J, Endres I, Tonenchi L, Teshome MY, Wetzke M, Klein W, Lohse P, Ochsenkühn T, Folwaczny M, Göke B, Folwaczny C, Müller-Myhsok B, Brand S.
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [Abstract] [Full Text] [Related]

  • 13. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
    Weersma RK, Oostenbrug LE, Nolte IM, Van Der Steege G, Oosterom E, Van Dullemen HM, Kleibeuker JH, Dijkstra G.
    Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
    [Abstract] [Full Text] [Related]

  • 14. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.
    Büning C, Schmidt HH, Molnar T, De Jong DJ, Fiedler T, Bühner S, Sturm A, Baumgart DC, Nagy F, Lonovics J, Drenth JP, Landt O, Nickel R, Büttner J, Lochs H, Witt H.
    Aliment Pharmacol Ther; 2007 Oct 01; 26(7):1025-33. PubMed ID: 17877509
    [Abstract] [Full Text] [Related]

  • 15. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
    Molnar T, Hofner P, Nagy F, Lakatos PL, Fischer S, Lakatos L, Kovacs A, Altorjay I, Papp M, Palatka K, Demeter P, Tulassay Z, Nyari T, Miheller P, Papp J, Mandi Y, Lonovics J, Hungarian IBD Study Group.
    Dig Liver Dis; 2007 Dec 01; 39(12):1064-70. PubMed ID: 17964870
    [Abstract] [Full Text] [Related]

  • 16. Frequencies of genetic polymorphisms of TLR4 and CD14 and of HLA-DQ genotypes in children with celiac disease, type 1 diabetes mellitus, or both.
    Dezsofi A, Szebeni B, Hermann CS, Kapitány A, Veres G, Sipka S, Körner A, Madácsy L, Korponay-Szabó I, Rajczy K, Arató A.
    J Pediatr Gastroenterol Nutr; 2008 Sep 01; 47(3):283-7. PubMed ID: 18728522
    [Abstract] [Full Text] [Related]

  • 17. Association between the promoter polymorphism T/C at position -159 of the CD14 gene and anti-inflammatory therapy in patients with inflammatory bowel disease.
    Griga T, Wilkens C, Schmiegel W, Folwaczny C, Hagedorn M, Duerig N, Epplen J, Klein W.
    Eur J Med Res; 2005 May 20; 10(5):183-6. PubMed ID: 15946916
    [Abstract] [Full Text] [Related]

  • 18. TLR4 D299G polymorphism modulates cytokine expression in ulcerative colitis.
    Meena NK, Verma R, Verma N, Ahuja V, Paul J.
    J Clin Gastroenterol; 2013 Oct 20; 47(9):773-80. PubMed ID: 23470644
    [Abstract] [Full Text] [Related]

  • 19. Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases.
    Wolfkamp SC, Verstege MI, Vogels EW, Meisner S, Verseijden C, Stokkers PC, te Velde AA.
    Eur J Gastroenterol Hepatol; 2012 Aug 20; 24(8):965-70. PubMed ID: 22664939
    [Abstract] [Full Text] [Related]

  • 20. Impact of genetic variants of CD14 and TLR4 on subgingival periodontopathogens.
    Schulz S, Zissler N, Altermann W, Klapproth J, Zimmermann U, Gläser C, Schaller HG, Reichert S.
    Int J Immunogenet; 2008 Dec 20; 35(6):457-64. PubMed ID: 19046305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.